December 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outset Medical, Inc. (“Outset Medical” or “the Company”) (NASDAQ: OM). Investors who purchased Outset Medical securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Outset… read more
December 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Baidu, Inc. (“Baidu” or “the Company”) (NASDAQ: BIDU). Investors who purchased Baidu securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Baidu has violated federal… read more
December 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PetMed Express, Inc. (“PetMed” or “the Company”) (NASDAQ: PETS). Investors who purchased PetMed securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PetMed has violated… read more
December 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of New Era Energy & Digital, Inc. (“New Era” or “the Company”) (NASDAQ: NUAI). Investors who purchased New Era securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
December 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fermi Inc. (“Fermi” or “the Company”) (NASDAQ: FRMI). Investors who purchased Fermi securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Fermi has violated federal… read more
December 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coupang, Inc. (“Coupang” or “the Company”) (NYSE: CPNG). Investors who purchased Coupang securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Coupang has violated federal… read more
December 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Balancer (“Balancer” or “the Company”) (Other: BAL). Investors who purchased Balancer securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Balancer has violated federal securities… read more
December 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Klarna Group plc (“Klarna” or “the Company”) (NYSE: KLAR). Investors who purchased Klarna securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Klarna has violated… read more
December 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PagerDuty, Inc. (“PagerDuty” or “the Company”) (NYSE: PD). Investors who purchased PagerDuty securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PagerDuty has violated federal… read more
December 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. (“Acadia” or “the Company”) (NASDAQ: ACHC). Investors who purchased Acadia securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Acadia has… read more
December 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bath & Body Works, Inc. (“Bath & Body” or “the Company”) (NYSE: BBWI). Investors who purchased Bath & Body securities are encouraged to obtain additional information and assist the investigation. The… read more
December 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Home Depot, Inc. (“Home Depot” or “the Company”) (NYSE: HD). Investors who purchased Home Depot securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
December 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Village Farms International, Inc. (“Village Farms” or “the Company”) (NASDAQ: VFF). Investors who purchased Village Farms securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
December 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. (“Molina” or “the Company”) (NYSE: MOH). Investors who purchased Molina securities prior to February 5, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
December 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. (“PACS” or “the Company”) (NYSE: PACS). Investors who purchased PACS securities prior to April 11, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
December 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR). Investors who purchased Jasper securities prior to November 30, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
December 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RCI Hospitality Holdings, Inc. (“RCI” or “the Company”) (NASDAQ: RICK). Investors who purchased RCI securities prior to December 15, 2021, and continue to hold to the present, are encouraged to obtain… read more
December 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX). Investors who purchased Quanex securities prior to December 12, 2024, and continue to hold to the present, are encouraged to obtain… read more
December 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of KBR, Inc. (“KBR” or “the Company”) (NYSE: KBR). Investors who purchased KBR securities prior to May 6, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
December 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK). Investors who purchased Cytokinetics securities prior to December 27, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more
November 27, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sanara MedTech, Inc. (“Sanara” or “the Company”) (NASDAQ: SMTI). Investors who purchased Sanara securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sanara has violated… read more
November 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paysafe Limited (“Paysafe” or “the Company”) (NYSE: PSFE). Investors who purchased Paysafe securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Paysafe has violated federal… read more
November 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Danaher Corporation (“Danaher” or “the Company”) (NYSE: DHR). Investors who purchased Danaher securities prior to April 21, 2022, and continue to hold to the present, are encouraged to obtain additional information… read more
November 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Live Oak Bancshares, Inc. (“Live Oak” or “the Company”) (NYSE: LOB). Investors who purchased Live Oak securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
November 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT). Investors who purchased Ardent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ardent has violated… read more
November 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Logitech International S.A. (“Logitech” or “the Company”) (NASDAQ: LOGI). Investors who purchased Logitech securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Logitech has violated… read more
November 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Anavex Life Sciences Corp. (“Anavex” or “the Company”) (NASDAQ: AVXL). Investors who purchased Anavex securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Anavex has… read more
November 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC and KND Complex Litigation are investigating potential claims on behalf of purchasers of Ag Growth International Inc. (“Ag Growth” or “the Company”) (TSX: AFN). Investors who purchased Ag Growth securities are encouraged to obtain additional information and assist the investigation…. read more
November 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alibaba Group Holding Limited (“Alibaba” or “the Company”) (NYSE: BABA). Investors who purchased Alibaba securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alibaba has… read more
November 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CoreWeave, Inc. (“CoreWeave” or “the Company”) (NASDAQ: CRWV). Investors who purchased CoreWeave securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CoreWeave has violated federal… read more
